Regulatory Filings • Apr 29, 2013
Regulatory Filings
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information
RNS Number : 4718D
Silence Therapeutics PLC
29 April 2013
London, 29 April 2013
Silence Therapeutics plc ("Silence Therapeutics" or the "Company")
Result of General Meeting
Silence Therapeutics announces that at its General Meeting held earlier today, the resolutions as set out in the circular send to shareholders on 10 April 2013 in reference to the Placing of New Ordinary Shares and Share Consolidation were duly passed.
Silence Therapeutics
Tim Freeborn, finance director
+44 (0) 333 988 0140
N+1 Singer
Shaun Dobson/Jenny Wyllie
+44 20 7496 3057
This information is provided by RNS
The company news service from the London Stock Exchange
END
REGSEAFFUFDSESL
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.